Methods of Assessing a Risk of Cancer Progression
Methods and kits that use miRNA expression to predict the development of brain metastases in non-small cell lung cancer patients are disclosed.
WEISS GLEN [US]; KIM SEUNGCHAN [US]; NASSER SARA [US]
Type of Offer:
« More Biotech Patents